Life Sciences 1988-01-01

Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase.

P T Männistö, S Kaakkola, E Nissinen, I B Linden, P Pohto

Index: Life Sci. 43 , 1465, (1988)

Full Text: HTML

Abstract

Novel bisubstituted catechols were found to be potent and highly selective COMT inhibitors in vitro. One of them, OR-462 (3-(3,4-dihydroxy-5-benzylidene)-2,4-pentanedione), was studied also in vivo. When administered to rats orally together with levodopa and carbidopa, OR-462 greatly improved the bioavailability of levodopa and effectively reduced the formation of 3OMD. The levels of levodopa and dopamine were increased also in the striatum, and the 3OMD levels were decreased. The metabolic profile of dopamine demonstrated that COMT inhibition occurred in the peripheral tissues but not in the striatum. OR-462 thus resembled the peripheral inhibitors of dopadecarboxylase. These potent, selective and orally active COMT inhibitors offer a new tool for interfering in the metabolism of various COMT substrates.

Related Compounds

  • OR-486

Related Articles:

UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.

2014-05-01

[Neuropharmacology 82 , 76-87, (2014)]

Oxidative deamination of noradrenaline in human blood vessels.

1990-01-01

[J. Neural Transm. Suppl. 32 , 395-404, (1990)]

(−)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity

2000-01-01

[Arch. Biochem. Biophys. 573 , 84-91, (2015)]

Catechol-O-methyltransferase (COMT) inhibition reduces spinal nociceptive activity.

2010-04-12

[Neurosci. Lett. 473(3) , 212-5, (2010)]

Ultraviolet resonance Raman study of drug binding in dihydrofolate reductase, gyrase, and catechol O-methyltransferase.

1998-08-01

[Biophys. J. 75(2) , 1097-106, (1998)]

More Articles...